Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Interesting statement made in HEXO's financials
View:
Post by mdjbrown on Dec 15, 2022 10:32am

Interesting statement made in HEXO's financials

"MediPharm Onerous contract

During the period, the Company’s onerous contract provision related to a fixed price supply agreement for the supply of certain cannabis products was adjusted to the court settlement amount of $1,846, inclusive of $575 of accrued interest. Management has initiated an appeal against the court’s decision and is simultaneously pursuing a settlement with the counterparty."
Comment by Starkicker on Dec 15, 2022 2:47pm
So Hexo owes just $1.8M plus $575k interest instead of $9.8M? Hard to decipher that paragraph on its own. Hopefully that's not the case.
Comment by Stonksonlyup90 on Dec 15, 2022 3:11pm
Read their MD&A, under change in A/P: Atransferof$8,530owedtoacannabissupplierintosettlementliabilitiesandonerouscontractsastheresultofale Copy and paste not good on my phone. Maybe someone on a computer can correct 
Comment by Stonksonlyup90 on Dec 15, 2022 3:16pm
HEXO F/S are as at Oct/31, LABS as at Sept/30 - did they settle a portion in Sept?
Comment by mdjbrown on Dec 15, 2022 4:33pm
Starkicker, it is difficult to decipher the filings as when searching HEXO documents under Medipharm, very little appears.  Searching under onerous revealed a bit more. The court award included interest, so it would appear the interest accrued was $575,000.  Add that to the Medipharm $9.8 million court award and it is $10.375 million Adding the 2 HEXO reported totals of $8,530 and $1 ...more  
Comment by checkup on Dec 15, 2022 6:11pm
Thanks for the update about this deal.  LABS was my first and only investment in the MJ space way back in 2019 and I remember the HEXO default.  The court's finding is somewhat a surprise to me although I was always convinced of LABS' strong legal position.... but these days that doesn't seem to always matter. (i.e. the trucker protest)  
Comment by mdjbrown on Dec 16, 2022 10:10am
You are very welcome checkup It was encouraging to see that HEXO acknowledges the debt owed and that there is willingness to settle this debt owed. HEXO'S appeal filed in August will take time to work its way through the courts, but I would think HEXO is now on the clock for continued interest on the $9.8 million, and even at one percent interest, each passing day adds significantly to that ...more  
Comment by Starkicker on Dec 16, 2022 10:31am
Thanks MDJ, I appreciate it. Launching an appeal and pursuing a settlement at the same time sounds a bit desperate to me. Will definitely be nice to get this sorted, in the books and done with. Have a great weekend.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities